Literature DB >> 16189121

Effect of amphotericin B on capsule and cell size in Cryptococcus neoformans during murine infection.

Oscar Zaragoza1, Coralia Mihu, Arturo Casadevall, Joshua D Nosanchuk.   

Abstract

Antifungal drugs can affect the cellular morphology of Cryptococcus neoformans in culture, which alters its interactions with phagocytes. We examined the effects of amphotericin B on C. neoformans during murine infection. The antifungal reduced capsule size and serum polysaccharide, which suggests an additional mechanism for amphotericin B's efficacy in cryptococcosis.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16189121      PMCID： PMC1251559          DOI： 10.1128/AAC.49.10.4358-4361.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  23 in total

Review 1.  Capsule and melanin synthesis in Cryptococcus neoformans.

Authors:  D C McFadden; A Casadevall
Journal:  Med Mycol       Date:  2001       Impact factor: 4.076

2.  Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.

Authors:  M S Saag; R J Graybill; R A Larsen; P G Pappas; J R Perfect; W G Powderly; J D Sobel; W E Dismukes
Journal:  Clin Infect Dis       Date:  2000-04-20       Impact factor: 9.079

3.  Pharmacokinetics of amphotericin B in serum and tissues in mice treated with amphotericin B-Intralipid.

Authors:  Y Shadkchan; Z Zaslavsky; E Segal
Journal:  Med Mycol       Date:  2003-02       Impact factor: 4.076

4.  Dynamic changes in the morphology of Cryptococcus neoformans during murine pulmonary infection.

Authors:  Marta Feldmesser; Yvonne Kress; Arturo Casadevall
Journal:  Microbiology       Date:  2001-08       Impact factor: 2.777

5.  Capsule structure changes associated with Cryptococcus neoformans crossing of the blood-brain barrier.

Authors:  Caroline Charlier; Fabrice Chrétien; Marielle Baudrimont; Elodie Mordelet; Olivier Lortholary; Françoise Dromer
Journal:  Am J Pathol       Date:  2005-02       Impact factor: 4.307

6.  Distribution and activity of amphotericin B in humans.

Authors:  K J Christiansen; E M Bernard; J W Gold; D Armstrong
Journal:  J Infect Dis       Date:  1985-11       Impact factor: 5.226

7.  The antifungal drug amphotericin B promotes inflammatory cytokine release by a Toll-like receptor- and CD14-dependent mechanism.

Authors:  Keya Sau; Salamatu S Mambula; Eicke Latz; Philipp Henneke; Douglas T Golenbock; Stuart M Levitz
Journal:  J Biol Chem       Date:  2003-07-14       Impact factor: 5.157

8.  Long-lasting, specific immunologic unresponsiveness associated with cryptococcal meningitis.

Authors:  D K Henderson; J E Bennett; M A Huber
Journal:  J Clin Invest       Date:  1982-05       Impact factor: 14.808

9.  The capsule of cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages.

Authors:  T R Kozel; E C Gotschlich
Journal:  J Immunol       Date:  1982-10       Impact factor: 5.422

10.  Interaction of chemotherapy and immune defenses in experimental murine cryptococcosis.

Authors:  J R Graybill; P C Craven; L F Mitchell; D J Drutz
Journal:  Antimicrob Agents Chemother       Date:  1978-11       Impact factor: 5.191
View more
  7 in total

1.  Macrolides Inhibit Capsule Formation of Highly Virulent Cryptococcus gattii and Promote Innate Immune Susceptibility.

Authors:  Shigeki Nakamura; Yurika Ikeda-Dantsuji; Lianjin Jin; Yoshitsugu Higashi; Masahiro Abe; Tatsuya Inukai; Minoru Nagi; Makoto Urai; Yoshitsugu Miyazaki
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

2.  Fungal cell gigantism during mammalian infection.

Authors:  Oscar Zaragoza; Rocío García-Rodas; Joshua D Nosanchuk; Manuel Cuenca-Estrella; Juan Luis Rodríguez-Tudela; Arturo Casadevall
Journal:  PLoS Pathog       Date:  2010-06-17       Impact factor: 6.823

Review 3.  The capsule of Cryptococcus neoformans.

Authors:  Arturo Casadevall; Carolina Coelho; Radames J B Cordero; Quigly Dragotakes; Eric Jung; Raghav Vij; Maggie P Wear
Journal:  Virulence       Date:  2018-08-01       Impact factor: 5.882

4.  Antiphagocytic protein 1 increases the susceptibility of Cryptococcus neoformans to amphotericin B and fluconazole.

Authors:  Muhammad Ghaffar; Cody Orr; Ginny Webb
Journal:  PLoS One       Date:  2019-12-04       Impact factor: 3.240

Review 5.  The Environmental Effects on Virulence Factors and the Antifungal Susceptibility of Cryptococcus neoformans.

Authors:  Mahek Momin; Ginny Webb
Journal:  Int J Mol Sci       Date:  2021-06-11       Impact factor: 5.923

6.  Antifungal Combination of Ethyl Acetate Extract of Poincianella pluviosa (DC.) L. P. Queiros Stem Bark With Amphotericin B in Cryptococcus neoformans.

Authors:  Gabriella Maria Andriani; Ana Elisa Belotto Morguette; Laís Fernanda Almeida Spoladori; Patrícia Morais Lopes Pereira; Weslei Roberto Correia Cabral; Bruna Terci Fernandes; Eliandro Reis Tavares; Ricardo Sérgio Almeida; Cesar Armando Contreras Lancheros; Celso Vataru Nakamura; João Carlos Palazzo Mello; Lucy Megumi Yamauchi; Sueli Fumie Yamada-Ogatta
Journal:  Front Microbiol       Date:  2021-06-10       Impact factor: 5.640

7.  Lactoferrin Is Broadly Active against Yeasts and Highly Synergistic with Amphotericin B.

Authors:  Kenya E Fernandes; Kerry Weeks; Dee A Carter
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.